%20--%3e%3csvg%20version='1.1'%20id='圖層_1'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%201920%201740.5'%20style='enable-background:new%200%200%201920%201740.5;'%20xml:space='preserve'%3e%3cstyle%20type='text/css'%3e%20.st0{fill:%23922783;}%20%3c/style%3e%3cpath%20class='st0'%20d='M1900.8,31.3H19.2C8.6,31.3,0,39.9,0,50.5v153.6c0,10.6,8.6,19.2,19.2,19.2h1881.6c10.6,0,19.2-8.6,19.2-19.2%20V50.5C1920,39.9,1911.4,31.3,1900.8,31.3z%20M1900.8,1528.9H19.2c-10.6,0-19.2,8.6-19.2,19.2v153.6c0,10.6,8.6,19.2,19.2,19.2h1881.6%20c10.6,0,19.2-8.6,19.2-19.2v-153.6C1920,1537.5,1911.4,1528.9,1900.8,1528.9z%20M1900.8,780.1H19.2C8.6,780.1,0,788.7,0,799.3v153.6%20c0,10.6,8.6,19.2,19.2,19.2h1881.6c10.6,0,19.2-8.6,19.2-19.2V799.3C1920,788.7,1911.4,780.1,1900.8,780.1z'/%3e%3c/svg%3e)
台灣本土的 IBD研究 T-RUST ( 喜達諾在台灣最重要的研究)
由 TASID（台灣腸道醫學會） 多中心合作完成的研究： “Real-world effectiveness, durability, and safety of ustekinumab in inflammatory bowel disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study)” 正式獲國際知名期刊 Inflammatory Bowel Diseases 接受發表！
